Litigation Details for NOVO NORDISK INC. v. SANDOZ INC. (D.N.J. 2020)
✉ Email this page to a colleague
NOVO NORDISK INC. v. SANDOZ INC. (D.N.J. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-06-04 |
Court | District Court, D. New Jersey | Date Terminated | 2020-08-04 |
Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
Jury Demand | None | Referred To | Ann Marie Donio |
Patents | 6,268,343; 7,762,994; 8,114,833; 8,579,869; 8,846,618; 9,265,893 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in NOVO NORDISK INC. v. SANDOZ INC.
Biologic Drugs cited in NOVO NORDISK INC. v. SANDOZ INC.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for NOVO NORDISK INC. v. SANDOZ INC. (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-06-04 | 1 | United States Patent Nos. 6,268,343 (the “’343 patent”), 7,762,994 (the “’994 patent”), 8,114,833 (the… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,268,343 21. Novo Nordisk re-alleges …(the “’833 patent”), 8,579,869 (the “’869 patent”), 8,846,618 (the “’618 patent”), and 9,265,893 (the… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 5. On July 31, 2001, the United States Patent and Trademark | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |